QIPT News & Events

Quipt Home Medical announced completion of the previously-announced plan of arrangement under the provisions of the Business Corporations Act in accordance with an arrangement agreement dated December 14, 2025 among the Company, 1567208 B.C. and REM Aggregator. Pursuant to the Arrangement, and in accordance with the terms of the Arrangement Agreement, the Purchaser, which included funding from, amongst others, affiliates of each of Kingswood Capital Management, and Forager Capital Management acquired all of the issued and outstanding common shares of the Company for cash consideration of $3.65 per Share. Upon completion of the Arrangement; each outstanding option to acquire Shares outstanding immediately prior to completion of the Arrangement was deemed to be unconditionally vested and exercisable and such Quipt Option was, without any further action by, or on behalf of, the holder of such Quipt Option, deemed to be surrendered and transferred by such holder to the Company, in exchange for solely a cash payment from the Company, in an amount equal to the product of the number of Shares underlying such Quipt Option, multiplied by the amount by which the Consideration exceeded the exercise price of such Quipt Option, and each such Quipt Option was immediately cancelled; and each restricted share unit of the Company outstanding immediately prior to completion of the Arrangement was, without any further action by or on behalf of the holder of such Quipt RSU, deemed to be transferred by such holder to the Company in exchange solely for a cash payment in an amount equal to the Consideration and all Quipt RSUs were immediately cancelled. With the completion of the Arrangement, the Shares ceased trading on, and will be delisted from, the Nasdaq Capital Markets and will cease trading on, and be delisted from, the Toronto Stock Exchange at close of business on March 17, 2026. The Company intends to apply to cease to be a reporting issuer in Canada and to terminate its public reporting obligations in Canada and the U.S.

The major averages had a down day as markets enter the final full trading week of 2025, with investors responding to recent rally attempts and bouts of tech selloff pressure.Last week's mixed performance and rotation suggests investors are beginning to weigh earnings fundamentals more heavily than lofty growth multiples. Treasury yields have moved sideways after recent volatility, and risk appetite seems to be stabilizing, but only tentatively, as incoming economic indicators and central-bank decisions in both the U.S. and Europe remain key catalysts.Gold prices were fractionally higher as the commodity once again reaches for record highs, while oil finished lower.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Intelis in discussions to acquire SambaNova for $1.6B,ServiceNowis close to a $7B deal for Armis,CencoraOneOncology from TPGfor $6BiRobotentered into ato be acquired by PiceaLuminarinitiatedand agreed to sell its photonics business to Quantum Computingfor $110M2. WALL STREET CALLS:Texas Instrumentsto Sell from Buy at Goldman SachsAkamaito Overweight from Underweight at KeyBancAdobeto Underweight at KeyBancServiceNowto Underweight at KeyBancGoldman SachsLas Vegas Sands, Marriottand Hiltonto Buy as the firm adjusted ratings in the gaming and lodging group as part of its 2026 outlook3. AROUND THE WEB:Xeroxis working on a debt financing that would use its IP as collateral,A collaboration between Matteland Microsoft-backedOpenAI won't emerge this year,Nvidiahas told some Chinese clients that it is evaluating adding production capacity for its H200 AI chips after orders exceeded its output levels,TPGhas exited most of its $600M stake in Anastasia Beverly Hills as part of a debt restructuring,U.S. District Judge George Wu in California ruled Live Nationand its subsidiary Ticketmaster must face a class action for allegedly overcharging its customers for events at major venues across the country,4. MOVERS:Kyverna Therapeuticsincreases after announcing data from itsImmunomegains after announcing its RINGSIDE trial metZIMhigher in New York after announcingto vote 'FOR' all eight of the company's director nomineesCritical Metalsfalls afterfrom its 2024 drilling program at the Tanbreez Rare Earth ProjectZillowand CoStarlower as Google5. EARNINGS/GUIDANCE:Quipt Home Medical, with CEO Gregory Crawford commenting, "Our fiscal 2025 performance underscores both the durability of our model and the accelerating momentum"Highway Holdings, with EPS and revenue lower year-over-yearOcean PowerreportedEdesa Biotechreported, with EPS missing consensusEnWave, with EPS and revenue higher year-over-yearINDEXES:The Dow fell 41.49, or 0.09%, to 48,416.56, the Nasdaq lost 137.76, or 0.59%, to 23,057.41, and the S&P 500 declined 10.90, or 0.16%, to 6,816.51.